Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$plrz is up to something
Might be good;)
Typical........and NOT surprized...........I Trust NO ONE in power.......they are ALL Crooks......and get away with whatever they want.......
The only way to win is to move in synch with them................
Z
Not related but Jesus Christ lol
Huh? 🤔
— Polish Assassin2.0 (@FlyEaglesFly529) July 17, 2025
If that weren’t enough, new documents reveal that Consolidated Audit Trail LLC (CAT)—the very entity designed to bring transparency to Wall Street—has funneled over $706 million to “unrelated third parties” with no explanation.From CAT’s Form 990:
It's only DATA.......you can read it how you like.........lol
Z
U must be blind PLRZ
I was gonna say I looked all over and didn't see anything about a RS.I think we go north of $5 this year
Wrong! Why are you misleading people? It's your choice. GLTY...NOt!
YES and ! for 250 R/S
YEs I too remember DRYS went private..
the chart is BS PLRZ And or I could say MISLEADING
PLRZ did a R/S this morning at grate loss. In E/X AM
Sky's the limit Z
It's all fun and games until some rich fat cat runs into a wall with a hard on.........and breaks his nose first!!
Until the monkey boys of the naz decide to halt
I'd take 700%
Who wants em lol
Polyrizon Retains Nasdaq Listing Following Hearings Panel
July 15, 2025
Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced that it has received a notification letter from the Nasdaq Hearings Panel (the “Panel”) granting the Company’s request for the continued listing of its securities on the Nasdaq Capital Market.
As previously reported by the Company on May 23, 2025, the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) issued a public interest determination under Listing Rule 5101, citing the Company’s issuance of securities in a private placement (the “Private Placement”) pursuant to the securities purchase agreement dated March 31, 2025, particularly the Series A warrants exercisable on an alternate cashless basis. In connection with the Private Placement, the Company issued an aggregate of 5,962,073 ordinary shares, which includes 5,829,389 ordinary shares issued upon the exercise of warrants on an alternate cashless basis. As of the date hereof, all of the warrants issued in the Private Placement have been exercised.
A hearing before the Panel was held on June 26, 2025. At the hearing, Polyrizon presented its plan to address Nasdaq’s concerns, including a commitment to avoid the use of overly complex or inherently dilutive financing instruments in future capital-raising activities.
On July 9, 2025, the Panel issued its determination, granting the Company's request for continued listing on the Nasdaq Capital Market, subject to the Company regaining compliance with the Minimum Bid Price Rule by October 17, 2025.
“We appreciate Nasdaq’s thoughtful consideration of this matter and are pleased to maintain our listing on Nasdaq,” said Tomer Izraeli, CEO of Polyrizon Ltd. “Following the Private Placement, we have a cash balance of approximately $15.68 million. With the full exercise of the warrants issued in that transaction, we have meaningfully simplified our capital structure, eliminating a significant source of potential dilution and overhang. We believe this positions us well to enhance long-term shareholder value and better reflect the strength of our underlying business.
“In addition, we are implementing a formal internal control framework to govern future securities issuances and ensure ongoing compliance with Nasdaq listing standards,” Mr. Izraeli added. “This includes enhanced oversight of financing activity, Nasdaq-related reporting, and quarterly internal compliance reviews, which will be reported to our Audit Committee.”
About Polyrizon
Polyrizon is a development stage biotech company specializing in the development of innovative medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Polyrizon’s proprietary Capture and Contain TM, or C&C, hydrogel technology, comprised of a mixture of naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a “biological mask” with a thin shield containment barrier in the nasal cavity. Polyrizon are further developing certain aspects of our C&C hydrogel technology such as the bioadhesion and prolonged retention at the nasal deposition site for intranasal delivery of drugs. Polyrizon refers to its additional technology, which is in an earlier stage of pre-clinical development, that is focused on nasal delivery of active pharmaceutical ingredients, or APIs, as Trap and Target ™, or T&T. For more information, please visit https://polyrizon-biotech.com.
https://ih.advfn.com/stock-market/NASDAQ/polyrizon-PLRZ/stock-news/96430761/polyrizon-retains-nasdaq-listing-following-hearing
$PLRZ
Glenn
Is it too much to ask for a new 52 week high???
lolLet's go!!!
plrz...............................................https://stockcharts.com/h-sc/ui?s=PLRZ&p=W&b=5&g=0&id=p86431144783
PT $2.50If SS is correct and that's just cash
Compliance and warrants completed$15.68m cash
Ya this going hard if the fuktards on naz don't fuk it up.
All the data is from 5-30-25
No new data
Nobody knows
Guys showing screenshots of data from half a month ago lol.
Looks like shorts have covered and with very little upside movement. Significant Failures to Deliver
No . Still hope to see some good news but i think that's a long shot. Best of luck
Need to see the new short interest It's 6/17.....should have been out by now. MM must have oversold short a new record lol
Motley check Premarket Getting frisky?
For 5/14 238k ftdhttps://chartexchange.com/symbol/nasdaq-plrz/failure-to-deliver/
Borrow rate still 189%
Significant Failures to Deliver
Yes
https://www.otcmarkets.com/stock/PLRZ/security
Reminds me of DRYS Dry ships out a Greece Butt load of RS and then it went from like .03 to 92.5 lol
SI still 1,000% per fintel. Thats 50 million naked borrowed shares. Only a matter of time before another tute sees the easy money grab here.
Borrow rate is now 170%
My thinking remains. Why stay if one believes it will be delisted?
If my memory serves me correct. Seems I remember reading in one of the recent filings they were going to keep the Authorized Shares at 2 Billion. I’ll have to look again but I’m pretty sure they stated such in a filing pertaining to the reverse split announcement.
We've been here for a while buddy. Your late to the party. Stocks change like the wind based on new info. And they've already been warned but it looked a little promising after the reverse split. But now it appears they are just going to dillute the piss out of this and not even care and just play games and steal as much money as possible before they exit the NASDAQ with a big wad of cash in managements pockets while we are left with nothing. Happens all the time. Penny Stocks are mostly just legalized theft with no actual plans to ever really have a legit business. They just come up with a catchy or trendy idea that sounds good and are granted a ticker. All you need is a ticker to sell shares and your rich and you can do it over and over again the more you learn how to navigate the system and the more crooks you get to know.
got cha back cheers POLYRIZON
So if you believe "they" could be delisted what are you doing still in it?
I'm getting out Monday I think. They keep closing below $1. This could get delisted at any second.
Nerve wracking for sure
Polyrizon's Retail Following Booms As Biotech Stock Triples On Manufacturing Deal For Allergy Blocker Trial
This collaboration will supply clinical trial material for Polyrizon’s experimental allergy blocker, PL-14, which is set to enter clinical trials in 2025.
Ya I'm staying with that borrow rate. Sitting on my hands lol
This price action suggests games being played to entice us to sell before next weeks rally. Just my opinion.
Needs volume. Some news would send this flying.
Borrow rate is 16,800% nowShould be squeezing if time is money lol
IF those numbers are correct buckle up buttercup.. PLRZ
When you put it that way.....damn smart.
Followers
|
17
|
Posters
|
|
Posts (Today)
|
1
|
Posts (Total)
|
433
|
Created
|
10/30/24
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |